Groundbreaking science is just the beginning. What truly determines a longevity company’s success is how vision translates into strategy — and how both align with culture, compliance, and execution. In this panel, seasoned founders, HR experts, and industry partners discuss what it takes to build and scale a company in the rapidly evolving longevity space. From assembling mission-driven teams to navigating the complexities of regulation, risk, and growth, this conversation explores how the right structure, culture, and strategy can turn scientific potential into lasting impact. Featuring insights from leaders at VensureHR, Newfront Insurance, and pioneering entrepreneurs who’ve built companies at the intersection of biotech and business. #Longevity #Biotech #LATechWeek #InvestInHealthspan @Techweek_ @ZuberLawler @VensureHR @NewfrontHQ

We’re just 10 days away from our Los Angeles Longevity Investors Summit! We have an incredible lineup of speakers—many of whom you’ve never seen in the same room before! Whether you’re a grassroots member, a startup founder, an investor, or part of an industry preparing for transformative change due to our aging population, this is your chance to join the conversation on longevity science! Don’t get FOMO. Be part of the dialogue that’s shaping the future! Event program here: a4li.org/a4li-longevity-inve…. #Longevity #Biotech #LATechWeek #InvestInHealthspan @Techweek_

In case you missed it, a hot-mic moment at Beijing’s WWII anniversary parade this week captured Xi and Putin discussing immortality and the future of human longevity. But the real story is about how China and Russia are making longevity and biotechnology national priorities. 𝐂𝐡𝐢𝐧𝐚’𝐬 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐲: China has rolled out aggressive, state-backed investment in biotechnology, organ transplants, AI-driven health platforms, and anti-aging research, reportedly spending tens of billions of dollars annually on these initiatives. Its government views biotech as central to both economic growth and geopolitical power, pouring resources into labs and encouraging public-private collaboration. 𝐑𝐮𝐬𝐬𝐢𝐚’𝐬 𝐀𝐩𝐩𝐫𝐨𝐚𝐜𝐡: Putin has long talked about extending human life, linking it to national strength. Russia has invested in organ transplant programs and biotech startups, with spending estimated at hundreds of millions to low billions of dollars annually, though still far below China’s scale. Still, Putin frames longevity as part of his vision of national renewal and global competition. 𝐔.𝐒. 𝐜𝐮𝐫𝐫𝐞𝐧𝐭 𝐞𝐟𝐟𝐨𝐫𝐭𝐬: In the U.S., significant progress is already underway. The @NIH provides over $47 billion in annual funding, making it the world’s largest supporter of biomedical research, while the @NIHAging, with its nearly $5 billion budget, drives cutting-edge aging and Alzheimer’s research. @ARPA_H launches high-risk, high-reward programs such as PROSPR (Proactive Solutions for Prolonging Resilience/@BrackLab) to accelerate breakthroughs in aging biology and chronic disease, and FRONT (Functional Repair of Neocortical Tissue) to advance regenerative approaches. Meanwhile, the Alliance for Longevity Initiatives (A4LI) is working to ensure Congress and the public understand what’s at stake and why America must lead in longevity science. By advocating for increased funding, strategic research programs, and policy support, A4LI helps lawmakers, investors, and the public recognize the critical steps needed for the U.S. to maintain its edge in this rapidly advancing field. To ensure Americans can achieve longer, healthier lives and to remain competitive with China and Russia, the U.S. must treat longevity as a national priority, scaling investment and coordinating efforts across research, policy, and innovation. Read more here: time.com/7314433/xi-putin-ch…

🚀 Calling all longevity biotech startups! We’re thrilled to announce the Longevity Investors Summit in Los Angeles, an official LA Tech Week event. With an impressive lineup of standout companies from the Bay Area and LA already confirmed, this gathering will bring together investors, innovators, and leaders shaping the future of longevity science. We are looking for companies to participate in our quick pitches. Reach out to [email protected] if you are interested! 📅 October 16, 2025 📍 Los Angeles, CA 🔗 Register here: partiful.com/e/No7MdW9oAAEGa….

✉ Let’s keep the momentum going. Help us reach 400 letters (and beyond)! Since July, our community has sent 375 letters to Congress urging support for longevity science. We’re so close to 400 and with Members of Congress in their final week of summer recess, this is the perfect time to get their attention about implementing A4LI’s proposals to drive aging research. It takes less than a minute: 1. Go to: actionnetwork.org/letters/dr… 2. Enter your name & address (so they know you’re a constituent). 3. Select your prefix and choose “Health” as the subject to ensure it lands in the right inbox. 4. Personalize the message if you’d like—or send it as-is. Share this link with friends, neighbors, and colleagues—multiple letters from one district push your Member higher on the priority list. Together, we can make healthy aging a Congressional priority. 💪

This week on A4LI’s Scientist Spotlight, we chat with Jillian Cox, PhD Candidate in Dr. Sarah Ocañas' (@OcanasSR) Lab at Oklahoma Medical Research Foundation (@OMRF). Growing up in Oklahoma, Jillian’s curiosity led her down the path of science. In our conversation, she shares how her background shaped her passion for research and walks us through her work on how sex chromosomes influence the differences we often see between men and women in brain diseases and disorders. You can listen to the full episode here: a4li.org/podcast/scientist-s…

Want to help push aging biology research forward? 🚀 You can make an impact today: 📝 Speak up — Contact your local representatives and state senators. Email us at [email protected] for tips on what to say. 💬 Share your story — Tell us why this research matters to you: forms.gle/pAHkG1UYGyuD8Smm7. Small actions today can lead to big breakthroughs tomorrow.

We're hosting a Longevity SF Hike at the end of the month! Come join us! Register here: lu.ma/5ch3zqmt.

We recently partnered with @OctaneOC to boost visibility for longevity science in the medical industry, as they explore The Science of Longevity at their Medical Innovation Forum this October. Join top leaders in medtech, healthcare, and investment for two days of cutting-edge content and high-impact networking — all at a discounted rate! 🎟 Use code ALIVIP for $200 off General Admission (2-Day or Single Day) at register.octaneoc.org/omif20…. Act now to take advantage of a bigger discount with their early bird pricing!

🚨 𝗧𝗵𝗲 𝗧𝗿𝗮𝗻𝘀-𝗡𝗜𝗛 𝗚𝗲𝗿𝗼𝘀𝗰𝗶𝗲𝗻𝗰𝗲 𝗜𝗻𝘁𝗲𝗿𝗲𝘀𝘁 𝗚𝗿𝗼𝘂𝗽 (𝗚𝗦𝗜𝗚) 𝗶𝘀 𝗯𝗮𝗰𝗸! Launched in 2012 by Dr. Felipe Sierra, then Director of the NIA Division of Aging Biology, the GSIG was established on the recognition that aging biology is a fundamental driver of most chronic diseases. Today, it includes participation from over 20 NIH Institutes — a much-needed cross-agency effort we’ve long championed! 𝗧𝗵𝗶𝘀 𝗧𝗵𝘂𝗿𝘀𝗱𝗮𝘆 (𝗝𝘂𝗹𝘆 𝟯𝟭), 𝘁𝗵𝗲 𝗚𝗦𝗜𝗚 𝘄𝗶𝗹𝗹 𝗳𝗲𝗮𝘁𝘂𝗿𝗲 𝗗𝗿. 𝗠𝗶𝗰𝗵𝗮𝗲𝗹 𝗦𝗻𝘆𝗱𝗲𝗿 (𝗦𝘁𝗮𝗻𝗳𝗼𝗿𝗱 𝗨𝗻𝗶𝘃𝗲𝗿𝘀𝗶𝘁𝘆) 𝗮𝗻𝗱 𝗗𝗿. 𝗦𝗵𝗶𝗻-𝗜𝗰𝗵𝗶𝗿𝗼 𝗜𝗺𝗮𝗶 (𝗪𝗮𝘀𝗵𝗶𝗻𝗴𝘁𝗼𝗻 𝗨𝗻𝗶𝘃𝗲𝗿𝘀𝗶𝘁𝘆 𝗶𝗻 𝗦𝘁. 𝗟𝗼𝘂𝗶𝘀) 𝗶𝗻 𝘁𝗵𝗲𝗶𝗿 “𝗔𝗱𝘃𝗮𝗻𝗰𝗲𝘀 𝗶𝗻 𝗚𝗲𝗿𝗼𝘀𝗰𝗶𝗲𝗻𝗰𝗲” 𝘄𝗲𝗯𝗶𝗻𝗮𝗿. 📅 Thursday, July 31 🕛 12–1 PM ET 👉 Register: events.gcc.teams.microsoft.c… 🔍 Learn more about GSIG: nia.nih.gov/gsig.

🚨 As agencies discuss the implementation of New Approach Methodologies (NAMs), it’s critical we don’t leave behind what still works. 🧬 Mice are still the gold standard for aging research, offering whole-organism insights, rapid testing, and decades of proven value. 📉 Replacing them too soon risks slowing down longevity drug development and stalling scientific progress. 💡 The NIA Intervention Testing Program (ITP) should be expanded, not reduced. A recent paper by leading researchers calls for biotech companies to implement leaner, cost-effective ITP-style studies during IND-enabling stages (aginganddisease.org/EN/10.14…) Excited to see where Olden Labs (go.oldenlabs.co/) come in on this! Let us know how your company is thinking about robust preclinical validation in aging.

This week on A4LI’s Scientist Spotlight, we chat with Seth Ashby,  a research associate in Dr. Angeli's lab at the University of Maine. In this episode, we discuss how Seth's experience working at a short-staffed nursing home during the pandemic led to him becoming interested in aging research, and how growing up in Maine has helped shape his passion for policy. You can listen to the full episode here: a4li.org/podcast/scientist-s….

We're just as excited about the new ARPA-H program, FRONT, as you are! It's truly transformative for patients currently suffering from permanent neurological damage with no immediate cure.